ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Remnant Cholesterol Inflammatory Index and its Association With Cardiometabolic Multimorbidity in Middle-Aged and Advanced-Aged Individuals: Evidence From the China Health and Retirement Longitudinal Study.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND The association between remnant cholesterol inflammatory index (RCII) and cardiometabolic multimorbidity (CMM) remains unclear. RCII is defined as: {Total Cholesterol - (High-Density Lipoprotein Cholesterol + Low-Density Lipoprotein Cholesterol)] × High-Sensitivity C-Reactive Protein/10}. This study examined the association between baseline RCII and CMM among middle-aged and older adults in China. MATERIAL AND METHODS This study analyzed data from the China Health and Retirement Longitudinal Study (CHARLS), including 6173 participants. CMM was defined as the coexistence of at least 2 of 4 conditions: hypertension, diabetes, heart disease, or stroke. Participants were grouped according to the quartiles of natural log-transformed RCII (lnRCII) values. Modified Poisson regression models, restricted cubic splines, and receiver operating characteristic curves were used to examine the relationship between lnRCII and CMM outcomes. RESULTS In the cohort, 1832 cases of CMM occurred, and the incidence of CMM was highest in the lnRCII highest-quartile group (P<0.001). In the fully adjusted model, each unit of increase in lnRCII was associated with a higher risk of CMM (RR=1.13, 95% CI: 1.09-1.16), and participants in the highest quartile had a higher risk than those in the lowest quartile (RR=1.69, 95% CI: 1.50-1.90). The area under the curve for lnRCII was 0.607 (95% CI: 0.592-0.622), indicating modest discriminatory ability. CONCLUSIONS Higher baseline lnRCII was associated with an increased risk of incident CMM in middle-aged and older Chinese adults. Although RCII may capture combined information on remnant cholesterol and inflammation, its clinical predictive value requires further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.